LP
GSK icon

LMR Partners’s GSK GSK Stock Holding History

LMR Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,200
Closed -$1.38M – 1636
2025
Q4 		$1.38M Hold
28,200
– – ﹤0.01% 905
2025
Q3 		$1.22M Sell
28,200
-19,100
-40% -$746K 0.01% 871
2025
Q2 		$1.82M Buy
+47,300
New +$1.81M 0.01% 668

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LMR Partners's GSK Position: Q1 2026 in Review

LMR Partners opened a new position in GSK (GSK) in Q1 2026: 980,479 shares worth $54.1M. The stake represents 0.12% of the portfolio and ranks #89 among its holdings. This is a return to the name: LMR Partners previously reported a position in GSK as recently as Q3 2025.

LMR Partners first reported a position in GSK in Q3 2022 and has held it in 12 quarters since. The position peaked at $128M in Q2 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • LMR Partners held 980,479 shares of GSK worth $54.1M as of Q1 2026.
  • GSK was a new LMR Partners position in Q1 2026.
  • GSK made up 0.12% of LMR Partners's portfolio in Q1 2026, its #89 holding.
  • LMR Partners first reported a position in GSK in Q3 2022 and has held it in 12 quarters since.
  • LMR Partners's GSK position peaked at $128M in Q2 2024.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.